NYSE: NOW · ServiceNow, Inc.Enhanced Equity Research · June 25, 2026
Equity Research Report
Analysis by Joseph Lefcoe
Enhanced Equity Research — ServiceNow, Inc. (NOW)
Enterprise Workflow LeaderAgentic AI Monetization Proof PointRule-of-50 FCF Compounder

NOW

ServiceNow, Inc. — Enhanced Equity Research
Current Price
$94
Market Cap
96.7B
52-Week High
211.48
52-Week Low
81.24
BUY
PT $139
+48% upside · High conviction

Investment Thesis — Best-in-Class Growth at a Reset Multiple

ServiceNow remains one of software's premier compounders — Q1 FY2026 beat every metric with total revenue of $3.77B (+22% YoY), subscription revenue of $3.67B, and cRPO of $12.64B (+22.5%), prompting management to raise full-year guidance. Despite the operational strength, the stock fell ~18% after the April print and trades near $94 (post 5-for-1 split), as the market re-rated the multiple on fears that agentic AI could erode seat-based SaaS economics. We see those fears as premature: Now Assist generated $750M ACV in Q1 alone, with the FY26 AI ACV target raised to $1.5B — evidence AI is currently additive to the platform. At a ~0.9 PEG and ~22x forward earnings — well below NOW's historical premium — risk/reward skews favorable for a business still growing 20%+ at best-in-class margins. The debate is no longer growth quality but durability of the multiple in an AI-uncertain world.

Q1 FY2026 — Beat & Raise, Multiple Reset — ServiceNow keeps compounding north of 20% with ~31% FCF margins, yet the stock de-rated to ~22x forward earnings on AI-disruption fears. Post 5-for-1 split (Dec 2025); all per-share figures split-adjusted.

Total Revenue (Q1'26)
$3.77B
+22% YoY · +19% cc
Revenue Growth YoY
+22%
Subscription mid-20s cc
Subscription Revenue
$3.67B
97% of total · +22% YoY
cRPO
$12.64B
+22.5% YoY · +21% cc
Non-GAAP Gross Margin
~82%
Subscription GM ~84%
Free Cash Flow Margin
~31%
Op margin ~29% non-GAAP
Non-GAAP EPS (Q1'26)
~$1.04
Split-adj · beat consensus
Customers >$5M ACV
630
+22% YoY · 16 deals >$5M NNACV

Quarterly Total Revenue Trend

$3.22B
Q2'25
$3.40B
Q3'25
$3.57B
Q4'25
$3.77B
Q1'26

Now Assist, cRPO Momentum & Platform Expansion

$750M
Now Assist ACV (Q1'26)
FY26 target raised to $1.5B
+22.5%
cRPO Growth YoY
$12.64B current RPO
16
Deals >$5M NNACV (Q1)
~80% YoY growth in mega-deals
DEC 2025
5-for-1 Stock Split
Split effective Dec 18, 2025; all per-share figures and the 52-week range ($81–$211) shown post-split.
JAN 2026
Q4'25 Blowout + $5B Buyback
Total revenue $3.57B (+20.5%), EPS $0.92, cRPO $28.2B (+26.5%); Board adds $5B to repurchase authorization.
APR 2026
Q1'26 Beat — Stock Falls ~18%
Beat every metric and raised guidance, but shares sold off on AI-disruption fears; Morgan Stanley cut target to $180, Goldman to $163.
JUN 2026
AI-Partnership Momentum
Bullish targets reiterated as Now Assist ACV scales; consensus stays Strong Buy (~$141 avg) despite multiple compression.
JUL 2026
Q2'26 Report (upcoming)
Guided to ~$3.82B subscription revenue (+21% cc) and ~19.5% cc cRPO growth — key test of the AI-additive thesis.

Forward Estimates, Surprises & Insider Activity

Forward Earnings Estimates

FY+1 EPS Consensus$4.35 (FY26 non-GAAP, split-adj.)
FY+2 EPS Consensus$5.30 (FY27 non-GAAP, split-adj.)
PEG Ratio0.89
Forward P/E22.1
EPS Revisions (90d)↑22 ↓6 (Net upward on estimates despite price-target cuts; revisions stayed positive as guidance was raised even while multiples compressed on AI sentiment)
Guidance AccuracyConsistently beats and raises — exceeded guidance on every topline and margin metric for 8+ consecutive quarters

Earnings Surprise Track Record

Q2'25 Est: $0.79 Act: $0.83 +5.1%
Q3'25 Est: $0.86 Act: $0.91 +5.8%
Q4'25 Est: $0.88 Act: $0.92 +4.5%
Q1'26 Est: $0.99 Act: $1.04 +5.1%
Beat Rate100% (4 of last 4)

Insider Activity (90 Days)

Net Buying/Selling+$3M
Sell/Buy RatioNet buyer (last 90d)
Constructive — executives cancelled 10b5-1 sell plans and the CEO bought in the open market, a positive signal vs. prior routine selling
CEO William McDermott bought 28,682 shares on Feb 27, 2026 (~$105, ~$3M) under a non-10b5-1 agreement, lifting direct holdings to ~158,234 shares; five senior execs terminated their Rule 10b5-1 plans.

Relative Valuation vs. Competitors

CompanyP/EEV/RevRev GrowthGross Margin
ServiceNow~22x~9x~18.6%~76.6%
Salesforce~20x~5x~10%~77%
Workday~22x~6x~12.5%~76%
Snowflake~125x~15x~30%+~67%
Microsoft~18x~9x~14%~69%
After a ~55% drawdown from its early-2025 peak and the Dec 2025 5-for-1 split, NOW's forward P/E (~22x) and EV/Revenue (~9x) have compressed to the most reasonable levels in years — EV/Rev now sits well below its ~15x historical median. On a growth-adjusted basis NOW screens attractively: high-teens revenue growth and best-in-class ~77% gross margins at a multiple in line with slower-growing CRM and WDAY, and far below hyper-growth SNOW. Versus mega-cap anchor MSFT, NOW trades at a modest, growth-justified premium. The peer set frames NOW as a quality compounder whose valuation has de-rated to near peer parity. Figures are researched best-estimates as of late June 2026 and vary by data source.

Price Targets & Scenarios

ScenarioPrice TargetAssumptionsProbability
AI re-acceleration$185Now Assist ACV blows past the raised $1.5B FY26 target; cRPO growth stays >20%; agentic AI proves additive (not cannibalistic) to seat-based pricing; multiple re-rates toward 30x+ forward earnings.30%
Durable 20% compounder$140Subscription revenue grows ~20–21% cc through FY26 as guided; FCF margin ~31%; AI contributes steadily but the market holds a ~22–24x forward multiple given AI-overhang uncertainty.45%
AI disruption / deceleration$80Agentic AI compresses seat-based SaaS economics; net-new ACV decelerates; enterprise IT budgets tighten; multiple stays de-rated near 18–19x forward, testing the 52-week low.25%

Probability-Weighted Target: $139 (≈ +48% vs ~$94)

$139
Weighted
Bull $18530%
Base $14045%
Bear $8025%

Analyst Consensus

Morgan Stanley
$180
Overweight
Goldman Sachs
$163
Buy
Benchmark
$130
Buy
Wells Fargo
$236
Overweight (Street high)
Strong Buy consensus from ~48 analysts. Average target ~$141 (median $140), implying roughly 50% upside from ~$94. Targets compressed after the April 2026 AI-disruption selloff, but ratings stayed overwhelmingly bullish.

Key Levels & Options Intelligence

S/RSupport & Resistance

52-Week High
$211.48
200-Day MA
$136.78
Resistance Zone
$104.10
Key Resistance · 50-Day MA
$99.24
Current Price
$94.00
Key Support
$83.00
52-Week Low
$81.24

OptOptions & Sentiment

  • Implied Volatility (30-Day): Roughly 38–42% annualized — elevated versus NOW's ~30% baseline, reflecting the drawdown from highs and the AI-monetization debate
  • Put/Call Ratio: ≈ 0.49 (volume) — call volume outpaces puts ~2:1, a constructive/contrarian-bullish tilt despite the bearish price trend
  • Put/Call IV Ratio (30-Day): ≈ 0.98 — near parity; puts and calls priced almost symmetrically, indicating no extreme directional fear
  • Short Interest: ≈ 61.0M shares · 5.9% of outstanding — moderate-to-elevated for a mega-cap; days-to-cover ~3–4
  • IV Rank / Percentile: Estimated ~55–70th percentile — IV above its 1-year average post-selloff, though off peak-volatility readings
  • Options Skew (30-Day): Mild put skew — downside puts carry a slight IV premium, typical for a stock in a confirmed downtrend; not panic-level
  • Max Pain / Open Interest: Heaviest OI around the $90–$100 strikes; max pain estimated near $95, close to spot — limited pinning pressure
  • 30-Day Expected Move: Approximately ±$10–$11 (≈ ±11%) implied by ATM straddle pricing off ~$95 spot

Systematic Conviction Score: 78/100 (High)

89
Analyst Alignment
30%
100
FCF Visibility
25%
50
Catalyst Clarity
20%
50
Valuation Safety
15%
85
Mgmt Quality
10%
Overwhelming analyst alignment (~89% Buy), best-in-class and growing FCF, and constructive insider buying anchor a High score. The main temper is valuation safety: while the stock sits ~48% below the weighted target, the absolute multiple remains premium and the AI-disruption overhang is a genuine structural risk.

Risk Assessment & Insider Signals

!Risk Factors

  • Valuation · Multiple Compression: NOW still commands a premium versus the broad market. Any growth deceleration or rate-driven de-rating of high-multiple software compresses the multiple faster than earnings can offset — the dominant driver of the ~18% April drop despite a beat.
  • AI Monetization Disappointment: Now Assist hit $750M ACV with the FY26 target raised to $1.5B — already priced in. Any stumble in Pro Plus/Enterprise Plus attach, agentic-AI adoption lag, or AI gross-margin drag (rising inference cost) would undercut the core bull thesis.
  • Macro · Enterprise IT-Spend Slowdown: NOW's land-and-expand model depends on net-new seats and module attach during budget cycles. A downturn or CIO budget freeze elongates sales cycles, pressures net-new ACV, and makes the FY26 subscription guide harder to hit.
  • Competition · Microsoft / Salesforce: Microsoft (Copilot, Power Platform) bundles workflow/agentic AI at aggressive price points, and Salesforce (Agentforce) targets the same ITSM/CSM agentic budget. Consolidation and pricing pressure could cap seat expansion and AI premium capture.
  • Pricing Transition · Seat-Based to Consumption: Agentic AI deflects human work, undermining the per-Fulfiller seat model that drives ARR. A shift toward consumption/outcome pricing creates revenue-architecture uncertainty — fewer seats could offset AI uplift and muddy forward visibility.
  • FX & Large-Deal Lumpiness: A growing share of revenue is international (USD strength is a cRPO headwind), and results increasingly hinge on a handful of large multi-year deals. Timing slippage across quarter-ends can cause cRPO/billings misses the market punishes given the premium multiple.

OOwnership & Insider Signals

  • Institutional Ownership ~85–90%: ~2,300+ institutions hold roughly 895M shares — the float is overwhelmingly institutional, typical of a mega-cap index constituent. Heavy passive + active growth-fund concentration makes flows sensitive to index rebalancing and growth-style rotation.
  • Top Holder · Vanguard Group (~9.5%): Vanguard is the largest holder at ~19.8M shares (~9.5%), recently adding ~395K shares (+2.0%) — predominantly passive index exposure across its institutional and total-market funds.
  • Top Holder · BlackRock (~8.9%): BlackRock disclosed ~18.25M shares (~8.9%) via Schedule 13G/A — passive iShares/index holdings. Together Vanguard + BlackRock control ~18% of shares outstanding.
  • Other Major Holders: State Street, JPMorgan, T. Rowe Price, Geode Capital, FMR (Fidelity), and Norges Bank round out the top roster — a blend of passive index and active growth mandates.
  • Insider Ownership <1–2%: Insiders hold under 1–2% on a diluted basis, mostly RSUs and performance equity. CEO McDermott's direct stake rose to ~158K shares after a Feb 2026 open-market purchase. Low insider ownership is normal for a professionally-managed mega-cap.
  • Index Membership: NOW is a member of the S&P 500 (and S&P 100), Nasdaq-100, and major growth/technology indices, ensuring deep passive demand and high liquidity but tying the stock to broad-market and growth-factor flows.

Quantified Risk Assessment

Severity Risk Factor Prob. PT Impact
High Valuation · Multiple Compression 35% -20%
High AI Monetization Disappointment 30% -18%
Medium Macro · Enterprise IT-Spend Slowdown 30% -12%
Medium Competition · Microsoft / Salesforce 35% -10%
Medium Pricing Transition · Seat-Based to Consumption 25% -12%
Low FX & Large-Deal Lumpiness 40% -7%

Summary

Rating
BUY
Conviction
High
Price Target
$139
Timeframe
12 mo
Upside
+48%
Position Size
3%-5%

Entry Strategy

1
Tranche 1 — 40%
~$94
Initiate at current levels — stock sits ~48% below the weighted target with a Strong Buy consensus and a reset multiple. Establish the core position now.
2
Tranche 2 — 35%
~$87
Add on weakness toward the lower channel between the 50-day MA and key support, improving cost basis if the AI-overhang selling persists.
3
Tranche 3 — 25%
~$82
Complete the position near $83 support / the $81 52-week low — a capitulation zone offering maximum margin of safety ahead of the Q2 print.
IMPORTANT DISCLAIMER: This analysis is for educational and research purposes only. Not financial advice. Past performance does not guarantee future results. Consult qualified financial professionals before making investment decisions. All investments carry risk of loss. The information presented is based on publicly available data as of June 25, 2026.